Evidence-based Management of Sickle Cell Disease

Author:   George R Buchanan, M D ,  M P H Afenyi-Annan, M D ,  Samir K Ballas, M D
Publisher:   Createspace Independent Publishing Platform
ISBN:  

9781502452788


Pages:   164
Publication Date:   09 September 2014
Format:   Paperback
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Our Price $95.04 Quantity:  
Add to Cart

Share |

Evidence-based Management of Sickle Cell Disease


Add your own review!

Overview

Sickle cell disease can be severe and disabling. When properly treated, patients live longer and with better quality life. This is a US government publication intended to provide evidence-based guidelines for the care of these patients for the use of all concerned providers as well as patients and family members. This book is available in print here for convenience.

Full Product Details

Author:   George R Buchanan, M D ,  M P H Afenyi-Annan, M D ,  Samir K Ballas, M D
Publisher:   Createspace Independent Publishing Platform
Imprint:   Createspace Independent Publishing Platform
Dimensions:   Width: 21.60cm , Height: 1.10cm , Length: 27.90cm
Weight:   0.395kg
ISBN:  

9781502452788


ISBN 10:   1502452782
Pages:   164
Publication Date:   09 September 2014
Audience:   General/trade ,  General
Format:   Paperback
Publisher's Status:   Active
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

Reviews

Author Information

These guidelines were developed by an expert panel composed of health care professionals with expertise in family medicine, general internal medicine, adult and pediatric hematology, psychiatry, transfusion medicine, obstetrics and gynecology, emergency department nursing, and evidence-based medicine. Panel members were selected by the National Heart, Lung, and Blood Institute's (NHLBI's) leadership. The purpose of these guidelines is to help people living with sickle cell disease (SCD) receive appropriate care by providing the best science-based recommendations to guide practice decisions. The target audience is primary care providers and other clinicians, nurses, and staff who provide emergency or continuity care to individuals with SCD. NHLBI sponsored the development of these guidelines to assist health care professionals in the management of common issues, including routine health maintenance, the recognition and treatment of common acute and chronic complications and comorbidities of SCD, as well as the indications for and monitoring of hydroxyurea and blood transfusion therapy. The guidelines address the care of infants, children, adolescents, and adults with SCD, with the goal of facilitating high-quality and appropriate care for all individuals with this disease. Professional Associations that endorse these guidelines: Academy of Emergency Medicine (AAEM) American Academy of Pediatrics (AAP) American Academy of Physician Assistants (AAPA) American Osteopathic Association (AOA) American Society of Hematology (ASH) American Society of Pediatric Hematology/Oncology (ASPHO) International Association of Sickle Cell Nurses and Physician Assistants (IASCNAPA) National Black Nurses Association (NBNA) National Initiative for Children's Health Quality (NICHQ) National Medical Association (NMA) Sickle Cell Disease Association of America (SCDAA)

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List